title: Cyclosporine: a new therapeutic option for severe, recalcitrant psoriasis.
abstract: Severe, recalcitrant psoriasis can be a physically, emotionally, and socially-debilitating disease. Cyclosporine is an important new option for the systemic treatment of this dermatologic disorder. Cyclosporine, an immunosuppressive agent used in the field of organ transplantation for more than a decade, has demonstrated marked efficacy in treating severe, recalcitrant psoriasis. However, its successful use requires patient education and careful, ongoing patient monitoring.
authors.forename: P
authors.initials: P
authors.lastname: Gilleaudeau
authors.forename: P B
authors.initials: PB
authors.lastname: McClelland
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D016903:Drug Monitoring; D006801:Humans; D008297:Male; D010353:Patient Education as Topic; D011565:Psoriasis / Q000188:drug therapy* / Q000503:physiopathology; D017211:Treatment Failure
chemical_list: D016572:Cyclosporine